Serlect

Active Ingredient(s): Sertindole
Category: Antipsychotic

Serlect Overview

Sertindole (brand names: Serdolect and Serlect) is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative. Sertindole is not approved for use in the United States and was discontinued in Australia in Janu...

Read more Serlect Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sertindole

Recent Serlect Forums:

Be the first to start a discussion about this drug.

Other drugs which contain Sertindole or a similar ingredient: (1 result)

• SERTINDOLE